Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDanish Breast Cancer Cooperative Group

About this trial

In breast cancer patients treated by mastectomy and adjuvant post-mastectomy radiation therapy (PMRT) reconstruction is often delayed until 6 - 12 month after completion of chemotherapy and PMRT, due to high risk of complication. In this trial the safety of the delayed-immediate reconstruction method is tested, where a skin sparing mastectomy and reconstruction with silicone implant is performed at primary surgery to save the native skin for the final delayed reconstruction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Woman >18 years who are offered a mastectomy for invasive breast can-cer pT1-3, pN0-N3, M0 and wish reconstruction. The patient can be inclu-ded no matter the status of estrogen receptor, progesterone receptor, malignancy grade, and HER2 status.

The patient is a candidate for loco-regional radiation therapy according to national or institutional guidelines.

Highly selected patients with inflammatory breast cancer, namely those with complete or near complete response to neoadjuvant systemic thera-py judged by imaging and clinical examination before surgery. Any skin edema and clinical signs of skin involvement must have disappeared during systemic therapy. It is highly recommended that the decision to offer an inflammatory breast cancer patient inclusion in the DBCG RT Recon trial is made during a multidisciplinary team conference.

Adjuvant systemic therapy with chemotherapy, endocrine therapy, anti-HER2 treatment and other targeted therapies used in the adjuvant setting either as new standard or as part of a trial during the course of the trial is accepted.

Disqualifiers

Pregnant or lactating.

Previous breast cancer or Ductal carcinoma in Situ (DCIS).

Bilateral breast cancer.

Previous radiation therapy to the chest region.

Trial design

Design model

Single group

Treatments tested in this trial

  • Delayed-immediate reconstruction

    Procedure/Surgery

    Skin sparing mastectomy and reconstruction with silicone implant or expander covered by pectoral muscle and mesh or matrix. Final reconstruction with any reconstructive procedure 6-12 months after completion of chemotherapy and RT.

  • Delayed reconstruction

    Procedure/Surgery

    Total mastectomy and delayed reconstruction:with any reconstructive procedure 6-12 months after completion of PMRT

Treatment groups

590 Participants
are divided into 2 treatment groups
Group A: A: Delayed-immediate reconstructionExperimental treatment 1 intervention
Group B: B: Delayed reconstructionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of patients with complications with surgical intervention

Number of patients with complication deeming surgical intervention necessary (excluding percutaneous drainage and antibiotic treatment for inflammation in cases without need for open drainage): * Infection * Hematoma * Loss of implant/expander * Necrosis * Seroma

Time frame
1 year after final reconstruction

Secondary outcomes

1

Number of patients with complications without surgical intervention

Number of patients with complication (Infection with need for antibiotics and/or necrosis) without intervention necessary

Time frame
1 year after final reconstruction
2

Depression

Degree of Depression measured by Becks Depression Inventory, BDII using a scale from 1 to 4, 4 being the worst

Time frame
10 years post-final reconstruction
3

Fear of cancer recurrence

Fear of cancer recurrence measured by Concerns About Recurrence Questionnaire-3 (CARQ-3 ) on a scale from 1 to 10, 10 worst (fear all the time)

Time frame
10 years post-final reconstruction
4

Patient´s satisfaction and quality of life (QoL)

Patient satisfaction and QoL measures by the BREAST-Q-instruments on a scale from 1 to 5, 5 being worst

Time frame
10 years post-final reconstruction

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.